In this exclusive sit-down, Dr. Satish opens up his journey from a young biology enthusiast to a celebrated scientist with a PhD in virology and two postdoctoral stints, including one at the prestigious Singapore-MIT Alliance. He’s been everywhere from Singapore to Chicago, and now he’s rocking the R&D scene back in India!
Dr. Satish’s story is nothing short of cinematic. Our hero shares his experiences working on cutting-edge projects like Parkinson's and Alzheimer's research and virus-associated cancers. But the plot twist? He made a dramatic return to India, leaving behind a promising academic career in the US. “It wasn’t easy, but my heart was always in India,” he says, sharing how family and cultural ties pulled him back home. And guess what? He’s not just any scientist—he’s the guy who helped build Anthem's biological division from the ground up!
In true star fashion, Dr. Satish talks about the “escape velocity” needed to transition from academia to running a team of 300 R&D scientists at Anthem. He adds, “We had to pick and choose people with the right mindset, attitude, and technical acumen, and put them together.”
He also reveals the mix of excitement and challenges that come with working at one of India's leading CROs. “We’ve been audited by the FDA five times, and our quality systems are top-notch,” he boasts, showcasing Anthem’s prowess in navigating global regulatory landscapes.
When asked about the hot topic of AI/ML and its influence in R&D, he gives us the inside scoop on the role of AI and deep-tech in modern research. Fearlessly embracing the AI era, he’s all about integrating cutting-edge technologies into Anthem’s processes, ensuring they stay ahead of the curve.
So, are you ready for an inspiring journey through the life of a rockstar scientist? Head over to Pharma Now's YouTube channel and dive into this captivating interview. From the labs of Chicago to the boardrooms of Anthem, Dr. Satish’s journey is the blockbuster story you didn't know you needed!
Watch the full interview here!
For more behind-the-scenes action and updates, stay tuned to Pharma Now!